|
|
 |
|
New Argus Safety™ updates will further enhance the most advanced adverse event management and reporting system in the world.
Irvine, CA – August 1, 2007 – Relsys International released Service Pack 1 (SP1) of the Argus Safety™ 4.2 Suite, adding important new regulatory support to its flagship software system. SP1 is a complete Argus suite release including Argus Safety™ and other modules such as Argus Insight™ and Argus Perceptive™. A key enhancement in this release is the introduction of the Data Lock Point functionality for improved support of periodic submissions as well as ad-hoc regulatory queries. SP1 also provides further innovation for the E2B functionality, specifically to streamline the increasing load of importing ICSRs from partners and regulators.
Sanket Agrawal, Relsys’ Chief Strategy Officer, said, “With the latest release of Argus Safety™ 4.2 SP1, Relsys ensures that our flagship product remains the most advanced adverse event management system in the world. Relsys continues to enable life science clients to meet their obligations to regulators in the most effective and efficient manner possible.”
Current Relsys clients may learn more about the Argus Safety™ Suite, including integrated risk management capabilities, at the upcoming Argus Safety User Group in Berlin, Germany. Please contact your account representative for more information regarding this event.
About Relsys International
Relsys International provides the industry-leading Argus suite, a complete systems solution for pharmacovigilance and risk management that helps pharmaceutical, biotech and medical device companies improve drug safety and ensure ongoing compliance with global regulations. The company, founded in 1987, works in partnership with its customers to develop and deliver innovative solutions to long-term business needs, and to provide critical components to support its clients’ corporate risk management strategies. Argus Safety™, the company’s flagship product, is the world’s best selling adverse event reporting software, and is used by more of the leading pharmaceutical companies than any other solution. Relsys is a privately held company, headquartered in Irvine, California.
For more information, contact Abdul Rastagar, Marketing Manager at info@relsys.net or call +1 949-453-1715.
Back to News Headlines
|
|
